v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating Activities:    
Net loss $ (4,790) $ (5,176)
Adjustments to reconcile net loss used in operating activities:    
Depreciation and amortization 622 525
Share-based compensation 2,503 738
Unrealized gain on short-term investments - trading (121)
Income tax benefit (253)
Non-cash consideration received in the form of convertible promissory notes (1,505)
Amortization of debt discount 99
Amortization of debt issuance costs 73
Change in fair value of derivative liability (1)
Finance costs 90
Effect of changes in assets and liabilities, net of acquisition:    
Accounts receivable (738)
Prepaid expenses and other current assets 76 (60)
ERC receivable 1,724 (735)
Operating lease right-of-use assets 67 28
Accounts payable, accrued expenses, and accrued interest (921) (796)
Contract liabilities 44
Operating lease liabilities (64) (35)
Net cash used in operating activities (3,356) (5,250)
Investing Activities:    
Purchases of investments – trading securities (655)
Proceeds from sale of investments – trading securities 565
Purchase of Lyvecom, Inc., net of cash acquired (4,222)
Purchases of software development costs (100)
Purchases of property and equipment (68) (77)
Purchases of intangible assets (8) (46)
Net cash used in investing activities (4,488) (123)
Financing Activities:    
Proceeds from sale of common stock offerings 18,596
Proceeds from sale of preferred stock offering 5,000
Payments for accrued offering costs related to common stock offerings (105)
Payments for offering costs related to preferred stock offerings (300) (180)
Payments for deferred offering costs (85)
Payment of notes payable (118) (9)
Net cash provided by financing activities 4,582 18,217
Net change in cash (3,262) 12,844
Cash and restricted cash - beginning of period 8,495 4,353
Cash and restricted cash - end of period $ 5,233 $ 17,197